Danilon equidos 1.5 g Granules for horses and ponies
Danilon equidos 1.5 g Granules for horses and ponies
Not authorised
- Suxibuzone
Product identification
Medicine name:
Danilon equidos 1.5 g Granules for horses and ponies
Danilon equidos 1,5 g kyrni fyrir hesta og smáhesta (pony).
Active substance:
- Suxibuzone
Target species:
-
Horse
-
Horse (pony)
Route of administration:
-
In-feed use
Product details
Active substance and strength:
-
Suxibuzone1.50/gram(s)10.00gram(s)
Pharmaceutical form:
-
Granules
Withdrawal period by route of administration:
-
In-feed use
-
Horse
-
Meat and offalno withdrawal periodNot to be used in animals intended for human consumption. Treated horses may never be slaughtered for human consumption. The horse must have been declared as not intended for human consumption under national horse passport legislation.
-
Milkno withdrawal periodNot to be used in animals intended for human consumption. Treated horses may never be slaughtered for human consumption. The horse must have been declared as not intended for human consumption under national horse passport legislation.
-
-
Horse (pony)
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QM01AA90
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Surrendered
Authorised in:
-
Iceland
Package description:
- (ID2): 1 unspecified outer container with 60 Sachet (Paper, Aluminium, PolyEthylene) with 10 gram(s) (600 gram(s))
- (ID1): 1 unspecified outer container with 18 Sachet (Paper, Aluminium, PolyEthylene) with 10 gram(s) (180 gram(s))
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Ecuphar Veterinaria S.L.U.
Marketing authorisation date:
Manufacturing sites for batch release:
- Esteve Pharmaceuticals S.A.
Responsible authority:
- Icelandic Medicines Agency
Authorisation number:
- IS/2/11/016/01
Date of authorisation status change:
Reference member state:
-
Germany
Procedure number:
- DE/V/0192/001
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
English (PDF)
Download Published on: 10/08/2022
How useful was this page?:
